These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35414540)

  • 21. Progress in the care of familial hypercholesterolaemia: 2016.
    Bell DA; Watts GF
    Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
    Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
    BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of familial hypercholesterolaemia: Community and clinical.
    Vallejo-Vaz AJ; Ray KK
    Atherosclerosis; 2018 Oct; 277():289-297. PubMed ID: 30270061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.
    Steyn K; Goldberg YP; Kotze MJ; Steyn M; Swanepoel AS; Fourie JM; Coetzee GA; Van der Westhuyzen DR
    Hum Genet; 1996 Oct; 98(4):479-84. PubMed ID: 8792826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia.
    Clarke RE; Padayachee ST; Preston R; McMahon Z; Gordon M; Graham C; Crook MA; Wierzbicki AS
    Heart; 2013 Feb; 99(3):175-80. PubMed ID: 23213176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment.
    Chua YA; Razman AZ; Ramli AS; Mohd Kasim NA; Nawawi H
    J Atheroscler Thromb; 2021 Oct; 28(10):1095-1107. PubMed ID: 33455995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Luwaert R; Heller FR
    Eur J Clin Invest; 2003 Jan; 33(1):1-9. PubMed ID: 12492446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified Canadian Definition for Familial Hypercholesterolemia.
    Ruel I; Brisson D; Aljenedil S; Awan Z; Baass A; Bélanger A; Bergeron J; Bewick D; Brophy JM; Brunham LR; Couture P; Dufour R; Francis GA; Frohlich J; Gagné C; Gaudet D; Grégoire JC; Gupta M; Hegele RA; Mancini GBJ; McCrindle BW; Pang J; Raggi P; Tu JV; Watts GF; Genest J
    Can J Cardiol; 2018 Sep; 34(9):1210-1214. PubMed ID: 30093300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
    Al-Rasadi K; Alhabib KF; Al-Allaf F; Al-Waili K; Al-Zakwani I; AlSarraf A; Almahmeed W; AlSayed N; Alghamdi M; Batais MA; Almigbal TH; Alnouri F; Kinsara A; Hammouda A; Awan Z; Kary H; Elamin OA; Zadjali F; Al-Jarallah M; Shehab A; Sabbour H; Amin H; Altaradi H
    Curr Vasc Pharmacol; 2020; 18(1):57-64. PubMed ID: 30289081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M
    Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.
    Birkenhead K; Sullivan D; Trumble C; Spinks C; Srinivasan S; Partington A; Elias L; Hespe CM; Fleming G; Li S; Calder M; Robertson E; Trent R; Sarkies MN
    BMJ Open; 2024 May; 14(5):e082699. PubMed ID: 38692720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.